¼ºñ½º »óǰ
¸®¼Ä¡ Á¤º¸
°í°´¼¾ÅÍ
°øÁö»çÇ×
´Ù¿î·Îµå
Financial
Information
e-Bond
Revolution
Market
Transparency
BONDWEB ½Ã½ºÅÛÀº ²÷ÀÓ¾ø´Â Á¤º¸Çõ½ÅÀ» ÅëÇØ ±ÝÀ¶ ¼±ÁøÈ¿¡ ±â¿©ÇÕ´Ï´Ù.
BONDWEB
º»µåÀ¥Plus
ÃֱٰԽù°
°æÁ¦Á¾ÇÕ´º½º
º¸µµÀÚ·á
½Ã°¡Æò°¡Ç¥
ÁÖ¿ä±Ý¸®
IRS/CRS
½ºÅ©·¦
ÇïÇÁµ¥½ºÅ©
´Ù¿î·Îµå¼¾ÅÍ
°øÁö»çÇ× & ´º½º
ÀÎÀçã±â
ENG
ÀÏÀÚ
ÆÄÀÏ
Á¦¸ñ
±â°ü¸í
05-28
[Market Analyst ÀÌÀç¿ø] ±¹³»ÁÖ½Ä ¸¶°¨ ½ÃȲ (26.05.28) - À̰É..
À¯¾ÈŸÁõ±Ç
05-28
[IBKÅõÀÚÁõ±Ç Á¤ÇüÁÖ] [IBKS Bond Inside] ÀÓµµ×ùÔ³, ÀÎÇ÷¹À̼Ç..
IBKÅõÀÚÁõ±Ç
05-28
[ÇÑÈÅõÀÚÁõ±Ç ÇÑÀ¯Á¤][À½½Ä·á] ºê·£µå°¡ ¼ýÀÚ¸¦ ¸¸µç´Ù
ÇÑÈÅõÀÚÁõ±Ç
05-28
(¹Ì·¡¿¡¼ÂÁõ±Ç °¹ÎÈñ) Ä·ºê¸®ÄÜ (688256 CH/¸Å¼ö/½Å±Ô) : Á¦ÀçÀÇ..
¹Ì·¡¿¡¼Â´ë¿ì
05-28
(¹Ì·¡¿¡¼ÂÁõ±Ç ¼¹ÌÈ) Biotech Investor Primer #3 : RNAi, ½Ã°£..
¹Ì·¡¿¡¼Â´ë¿ì
05-28
±Û·Î¹ú Àü·Â±â±â/¿¡³ÊÁö: ³×ÀÌÆ¼ºê DC(Á÷·ù) µ¥ÀÌÅͼ¾ÅÍÀÇ µîÀå
Çϳª±ÝÀ¶ÅõÀÚ
05-28
[½Å¿µÁõ±Ç ±èÈ¿Áø] AI°¡ ¾ø¾ú¾îµµ FOMO´Â ÀÖ¾úÀ» °ÍÀÌ´Ù
½Å¿µÁõ±Ç
05-28
[SK Áõ±Ç ¸®¼Ä¡¼¾ÅÍ]SKÁõ±Ç Research Signature #2. Á¼¾ÆÁö´Â ½Ã..
SKÁõ±Ç
05-28
½º³ë¿ìÇ÷¹ÀÌÅ©(SNOW.US): AI Á¦Ç°ÀÇ ¸ÅÃ⠱⿩ ½ÃÀÛ, Å« ÆøÀÇ B..
Çϳª±ÝÀ¶ÅõÀÚ
05-28
[Çö´ëÂ÷Áõ±Ç ÃÖÁ¦¹Î] 5¿ù ±ÝÅëÀ§ - ¾ðÁ¦, ¾ó¸¶³ª ºü¸£°Ô, ¾îµð±î..
Çö´ëÂ÷Áõ±Ç
05-28
Marvell Technology (MRVL.US): µµÆÄ¹ÎÀº ºÎÁ·, ¼ºÀåÀº ±¸Á¶Àû
Çϳª±ÝÀ¶ÅõÀÚ
05-28
(¹Ì·¡¿¡¼ÂÁõ±Ç ±èöÁß) 2Â÷ÀüÁö : °¡°Ý ¼ö¿ë·ÂÀÌ ´Ù¸¥ µ¥ÀÌÅÍ ¼¾..
¹Ì·¡¿¡¼Â´ë¿ì
05-28
[LS Edge] 5¿ù ±ÝÅëÀ§ Review: ¼¼ ¸¶¸® Åä³¢¸¦ ÀâÀ» ¼ö ÀÖ´Â Àλó..
LSÁõ±Ç
05-28
[IBKÅõÀÚÁõ±Ç Á¤¿ëÅÃ] [IBKS Economy Monitor] ¸ÅÆÄÀû ±Ý¸® µ¿°á..
IBKÅõÀÚÁõ±Ç
05-28
[2026³â ÇϹݱâ Å©·¹µ÷ ½ÃÀå Àü¸Á] µÚ·Î ¹Ì·ç±â
Çϳª±ÝÀ¶ÅõÀÚ
Àüü : 343
óÀ½
ÀÌÀü
[1]
[2]
[3]
[4]
[5]
´ÙÀ½
³¡À¸·Î
Ȩ > ¸®¼Ä¡Á¤º¸ >
ÃֱٰԽù°